ENDRA Life Sciences Inc. articles

With NAFLD and NASH now affecting well over 1 billion people globally, the world needs better diagnostics to accurately detect liver disease in an affordable, easy-touse and safe manner.

Abstract
Non-Alcoholic Fatty Liver Disease (NAFLD) and its inflammatory stage, Non-Alcoholic SteatoHepatitis (NASH), are now a global healthcare crisis, and the facts should frighten patients, healthcare providers and insurance companies alike.

Abdominal ultrasound imaging is a widely available, low cost, point of care procedure that is used in daily clinical practice as the first-line examination to identify liver steatosis in patients with increased liver blood exams or suspected NAFLD.

Despite the broad use of abdominal ultrasound imaging, its sensitivity among morbidly obese patients is low, and it may miss the diagnosis when the liver hepatic fat content is < 20%.

Thermoacoustic imaging is a technology that i